Recruiting studies: Oral Anticoagulant

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Alerting Providers at Patient Hospital Discharge to Consider Prescribing Rivaroxaban to Reduce Venous Thromboembolism
NA · 1 location(s) · Scott C. Woller, MD · NCT06232551 Timing to Restart Direct Oral Anticoagulants After Traumatic Intracranial Haemorrhage
Phase 3 · 2 location(s) · Walton Centre NHS Foundation Trust · NCT06322953 The Direct Oral Anticoagulation Versus Vitamin K Antagonist After Cardiac Surgery Trial
Phase 3 · 19 location(s) · Population Health Research Institute · NCT04284839 Timing of Resumption of Direct Oral Anticoagulants Following Polypectomy
NA · 1 location(s) · The University of Hong Kong · NCT06482333 Safety and Efficacy of Intravenous Thrombolysis in Patients With Ischemic Stroke and Direct Oral Anticoagulants Intake
Phase 4 · 14 location(s) · Insel Gruppe AG, University Hospital Bern · NCT06571149 Perioperative Anticoagulant Use for Surgery Evaluation -Virtual Visit (PAUSE-Virtual)
Phase N/A · 10 location(s) · McMaster University · NCT06844227 Stop or Ongoing Oral Anticoagulation in Patients Undergoing Pvp (SOAP)
NA · 1 location(s) · Clinique Pasteur · NCT03297281 International Care Bundle Evaluation in Cerebral Hemorrhage Research
Phase 4 · 54 location(s) · Region Skane · NCT06429332 Catheter Ablation Plus LAAO Versus Anticoagulation in Frail Elderly Patients With Atrial Fibrillation
NA · 1 location(s) · Guangdong Provincial People's Hospital · NCT07441382 The Association Between Non-vitamin K Antagonist Oral Anticoagulant Therapy and Acute Stroke Severity and Post Stroke Sh
Phase N/A · 1 location(s) · National Taiwan University Hospital · NCT05283174 Clinical Trial to Evaluate Efficacy and Safety of Rivaroxaban 15mg and 20mg in Patients With Non-valvular Atrial Fibrill
Phase 4 · 1 location(s) · Korea University Anam Hospital · NCT06187311 Apixaban-PK Trial: Preventing Portal Hypertension Complications in Cirrhosis
Phase 4 · 1 location(s) · Asian Institute Of Medical Sciences · NCT07521332 Adverse Drug Events in Patients on Oral Anticoagulation in the Emergency Department
Phase N/A · 1 location(s) · Centre Hospitalier Universitaire de Besancon · NCT06692504 Cardiac Assessment for Recurrent Stroke Risk Evaluation in Atrial Fibrillation
Phase N/A · 1 location(s) · Insel Gruppe AG, University Hospital Bern · NCT06954610 Direct Oral Anticoagulants for the Treatment of Cerebral Venous Thrombosis
Phase N/A · 1 location(s) · Academisch Medisch Centrum - Universiteit van Amsterdam (AMC · NCT04660747 Cohort of Patients With Left Ventricular Thrombus: Management and Outcomes in the Direct Oral Anticoagulants Era
Phase N/A · 1 location(s) · Insel Gruppe AG, University Hospital Bern · NCT05028777 The Study of Monitoring and Dosing Guidance of Direct Oral Anticoagulants Based on Pharmacokinetics, Pharmacodynamics, a
Phase N/A · 1 location(s) · Peking Union Medical College Hospital · NCT06362343 Risk Score of Embolism in Patients With AF Undergoing DOAC Therapy
Phase N/A · 2 location(s) · Hospital Universitari Vall d'Hebron Research Institute · NCT07713537 Hip Fracture Surgery Timing and Blood Transfusion Risk in Patients on DOACs
Phase N/A · 7 location(s) · St. Antonius Hospital · NCT07309848 International Registry of Thrombotic APS Patients Treated With Direct Oral Anticoagulants
Phase N/A · 1 location(s) · Stéphane Zuily · NCT04262492 Stroke Risk Assessment and Markers of Blood Clotting in Patients With Newly Diagnosed Non-valvular Atrial Fibrillation (
Phase N/A · 1 location(s) · Nedim Tojaga · NCT06949319 Oral Biopsy Bleeding in Patients on Direct Oral Anticoagulants (DOACs)
Phase N/A · 1 location(s) · University of Pisa · NCT07520890 Intravenous Thrombolytic Therapy in Acute Ischemic Stroke Patients on DOAC
NA · 1 location(s) · Chinese University of Hong Kong · NCT06241677 NOACs Use in AF or VTE (SUNSHINE Registry)
Phase N/A · 1 location(s) · Henan Provincial People's Hospital · NCT05378308 Intravenous Thrombolysis in Patients With Ischemic Stroke and Recent Ingestion of Direct Oral Anticoagulants
Phase N/A · 33 location(s) · Insel Gruppe AG, University Hospital Bern · NCT06556446 STrategies for Antithrombotic tReatment Following Transcatheter Edge-to-Edge Repair in Patients With an Indication for O
Phase 4 · 1 location(s) · Chinese Academy of Medical Sciences, Fuwai Hospital · NCT06901466 Rivaroxaban in Elderly Chinese Venous Thromboembolism Patients
Phase N/A · 1 location(s) · Peking Union Medical College Hospital · NCT06194617 Observational Study to Evaluate the Effectiveness of DOACS for Secondary Thrombosis Prevention in Low-risk Thrombotic AP
Phase N/A · 2 location(s) · Infanta Leonor University Hospital · NCT07372170 Study Protocol: Impact of Metamizole (Optalgin®) on Anti-Xa Concentrations in Oncology Patients Receiving DOACs
NA · 1 location(s) · Rambam Health Care Campus · NCT07384013 What is the Optimal Antithrombotic Strategy in Patients With Atrial Fibrillation Undergoing PCI?
Phase 4 · 20 location(s) · St. Antonius Hospital · NCT04436978

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.